| Title | Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. |
| Publication Type | Journal Article |
| Year of Publication | 2014 |
| Authors | Lawitz, Eric, Mark S. Sulkowski, Reem Ghalib, Maribel Rodriguez-Torres, Zobair M. Younossi, Ana Corregidor, Edwin DeJesus, Brian Pearlman, Mordechai Rabinovitz, Norman Gitlin, Joseph K. Lim, Paul J. Pockros, John D. Scott, Bart Fevery, Tom Lambrecht, Sivi Ouwerkerk-Mahadevan, Katleen Callewaert, William T. Symonds, Gaston Picchio, Karen L. Lindsay, Maria Beumont, and Ira M. Jacobson |
| Journal | Lancet |
| Date Published | 2014 Jul 26 |
| ISSN | 1474-547X |
| Abstract | Interferon-free regimens are needed to treat hepatitis C virus (HCV) infections. We investigated the efficacy of combined simeprevir and sofosbuvir. |
| DOI | 10.1016/S0140-6736(14)61036-9 |
| Alternate Journal | Lancet |
